Sofinnova Partners SAS

Sofinnova Partners SAS

Sofinnova Partners SAS

Overview
Date Founded

1997

Headquarters

17, rue de Surène,Paris, Ile-de-France 75008

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Private Equity & Venture Capital
Consumer Finance
Accounting & Financial Services
Investment Services & Portfolio Management

Company Description

Sofinnova Partners is an active manager which invests exclusively in life sciences and information technology firms in France, Europe, and to a limited extent, the US. They also have expertise in the clean technology sector. The firm aims to build companies from seed rounds to a trade sale or an IPO, investing in start-ups and early-stage companies with ambitious projects. They a minimum of 0.5 million euros per investment, and up to 20 million euros over several rounds of financing.Sofinnova acts as lead or co-lead investor, taking a seat on the board of directors and seeking to bring added value to the investee company management team.

Contact Data
Trying to get in touch with decision makers at Sofinnova Partners SAS? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Managing Partner & Chief Operating Officer

Managing Partner

Managing Partner

Managing Partner

General Counsel

Partner, Industrial Biotechnology Funds

Partner

Venture Partner, Medical Devices

Analyst

Board of Directors

Chairman at Sofinnova Partners SAS

Paths to Sofinnova Partners SAS
Potential Connections via
Relationship Science
You
Sofinnova Partners SAS
Recent Transactions
Details Hidden

Zambon Company SpA, Zambon Spa purchase Breath Therapeutics GmbH from Sofinnova Partners SAS, Gimv (Private Equity), Gilde Healthcare Partners BV

Details Hidden

Otsuka Holdings Co., Ltd. purchases ReCor Medical, Inc. from Sofinnova Partners SAS

Details Hidden

Sofinnova Partners SAS, Andera Partners SCA, BPIFrance Investissement SAS, MedDay Pharmaceuticals SAS purchase Profilomic SA /Health Division from Profilomic SA

Transaction Advisors
Legal Advisor

Advised onSofinnova Partners SAS purchases Sensitive Object SA

Legal Advisor

Advised onClovis Oncology, Inc. purchases EOS SpA from Sofinnova Partners SAS

Legal Advisor

Advised onClovis Oncology, Inc. purchases EOS SpA from Sofinnova Partners SAS

Associate

Advised onClovis Oncology, Inc. purchases EOS SpA from Sofinnova Partners SAS

Associate

Advised onClovis Oncology, Inc. purchases EOS SpA from Sofinnova Partners SAS

Legal Advisor

Advised onClovis Oncology, Inc. purchases EOS SpA from Sofinnova Partners SAS

Investments
Details Hidden

NOXXON Pharma NV is a clinical-stage biopharmaceutical company, which focuses on cancer treatment. Its oncology-focused pipeline acts on the cancer immunity cycle, which exposes hidden tumor cells by breaking the tumor protection barrier, blocking tumor repair. The company was founded on January 16, 2015 and is headquartered in Amsterdam, the Netherlands.

Details Hidden

CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France.

Details Hidden

Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sofinnova Partners SAS. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sofinnova Partners SAS's profile does not indicate a business or promotional relationship of any kind between RelSci and Sofinnova Partners SAS.